Distribution and prognostic value of high-sensitive troponin T measurement in patients with type 2 diabetes without cardiovascular disease

Pohlhammer, 2014, High-sensitivity cardiac troponin T in patients with intermittent claudication and its relation with cardiovascular events and all-cause mortality – the CAVASIC Study, Atherosclerosis, 237, 711, 10.1016/j.atherosclerosis.2014.10.097 Hochholzer, 2010, Novel biomarkers in cardiovascular disease: update 2010, Am Heart J, 160, 583, 10.1016/j.ahj.2010.06.010 Danese, 2016, An historical approach to the diagnostic biomarkers of acute coronary syndrome, Ann Transl Med, 4, 194, 10.21037/atm.2016.05.19 Sandoval, 2014, The global need to define normality: the 99th percentile value of cardiac troponin, Clin Chem, 60, 455, 10.1373/clinchem.2013.211706 Segre, 2015, Troponin in diabetic patients with and without chronic coronary artery disease, BMC Cardiovasc Disord, 15, 14, 10.1186/s12872-015-0051-z Thygesen, 2012, How to use high-sensitivity cardiac troponins in acute cardiac care, Eur Heart J, 33, 2252, 10.1093/eurheartj/ehs154 Motiwala, 2014, Biomarkers in ACS and heart failure: should men and women be interpreted differently?, Clin Chem, 60, 35, 10.1373/clinchem.2013.202531 Jaffe, 2014, High-sensitivity cardiac troponin assays: isn’t it time for equality?, Clin Chem, 60, 7, 10.1373/clinchem.2013.217927 Mueller-hennessen, 2016, Diagnostic and prognostic implications using age- and gender-specific cut-offs for high-sensitivity cardiac troponin T – sub-analysis from the TRAPID-AMI study, Int J Cardiol, 209, 26, 10.1016/j.ijcard.2016.01.213 Di Carli, 2003, Role of chronic hyperglycemia in the pathogenesis of coronary microvascular dysfunction in diabetes, J Am Coll Cardiol, 41, 1387, 10.1016/S0735-1097(03)00166-9 McNeely, 2009, The association between A1C and subclinical cardiovascular disease, Diabetes Care, 32, 1727, 10.2337/dc09-0074 Hitsumoto, 2015, Factors associated with high-sensitivity cardiac troponin t in patients with type 2 diabetes mellitus, J Nippon Med Sch, 82, 274, 10.1272/jnms.82.274 American Diabetes Association. Standards of medical care in diabetes D 2013. Diabetes Care. 2013;36(Suppl. 1):S11–66. doi:10.2337/dc13-S011. Price, 2017, Comparison of non-traditional biomarkers, and combinations of biomarkers, for vascular risk prediction in people with type 2 diabetes: The Edinburgh Type 2 Diabetes Study, Atherosclerosis, 264, 67, 10.1016/j.atherosclerosis.2017.07.009 Apple, 2017, Cardiac troponin assays: guide to understanding analytical characteristics and their impact on clinical care, Clin Chem, 63, 73, 10.1373/clinchem.2016.255109 Gore, 2014, Age- and sex-dependent upper reference limits for the high-sensitivity cardiac troponin T assay, J Am Coll Cardiol, 63, 1441, 10.1016/j.jacc.2013.12.032 Wu, 2018, Clin Chem, 655, 645, 10.1373/clinchem.2017.277186 Mckie, 2013, Defining high-sensitivity cardiac troponin concentrations in the community, Clin Chem, 1107, 1099, 10.1373/clinchem.2012.198614 Olivieri, 2012, Aged-related increase of high sensitive Troponin T and its implication in acute myocardial infarction diagnosis of elderly patients, Mech Ageing Dev, 133, 300, 10.1016/j.mad.2012.03.005 Rubin, 2012, Chronic hyperglycemia and subclinical myocardial injury, JAC, 59, 484 Zeller, 2014, High population prevalence of cardiac troponin I measured by a high-sensitivity assay and cardiovascular risk estimation: The MORGAM Biomarker Project Scottish Cohort, Eur Heart J, 35, 271, 10.1093/eurheartj/eht406 Brownlee, 2001, Biochemistry and molecular cell biology of diabetic complications, Nature, 414, 813, 10.1038/414813a Faden, 2013, The increasing detection of asymptomatic left ventricular dysfunction in patients with type 2 diabetes mellitus without overt cardiac disease: data from the SHORTWAVE study, Diabetes Res Clin Pract, 1 Giannitsis, 2014, Highly sensitive troponins knocking at the door of primary prevention, Eur Heart J, 35, 268, 10.1093/eurheartj/eht479 Evans, 2018, High-sensitivity cardiac troponin and new-onset heart failure: a systematic review and meta-analysis of 67,063 patients with 4,165 incident heart failure events, JACC: Heart Fail, 6, 187 Sarzani, 2017, Cardiac natriuretic peptides, hypertension and cardiovascular risk, High Blood Press Cardiovasc, 24, 115, 10.1007/s40292-017-0196-1 Everett, 2011, Sensitive cardiac troponin T assay and the risk of incident cardiovascular disease in women with and without diabetes mellitus the women's health study, Circulation, 123, 2811, 10.1161/CIRCULATIONAHA.110.009928 Everett, 2015, High-sensitivity cardiac troponin I and B-type natriuretic peptide as predictors of vascular events in primary prevention impact of statin therapy, Circulation, 131, 1851, 10.1161/CIRCULATIONAHA.114.014522 de Lemos, 2013, Association of serial measures of cardiac troponin T using a sensitive assay with incident heart failure and cardiovascular mortality in older adults, JAMA, 304, 2494 Vlachos, 2015, Troponin and cardiac events in stable ischemic heart disease and diabetes, N Engl J Med, 610 Twerenbold, 2015, Optimal cutoff levels of more sensitive cardiac troponin assays for the early diagnosis of myocardial infarction in patients with renal dysfunction, Circulation, 2041, 10.1161/CIRCULATIONAHA.114.014245 Gunsolus, 2017, Renal dysfunction influences the diagnostic and prognostic performance of high-sensitivity cardiac troponin I, J Am Soc Nephrol, 29, 1